Blog

AFCR announces the winners of the 2024 BRACE Award Venture Competition

Photo from AFCR/LinkedIn

Sep 7, 2024, 10:18

AFCR announces the winners of the 2024 BRACE Award Venture Competition

Asian Fund for Cancer Research (AFCR) shared a post on LinkedIn:

“AFCR is pleased to announce the winners of the 2024 BRACE Award Venture Competition: the First Prize goes to Concarlo Therapeutics, led by Founder and CEO Stacy Blain, Ph.D., and the Second Prize goes to Orphagen Pharmaceuticals, led by its Founder and CEO Scott Thacher, Ph.D.

For more information on why these incredible organizations were chosen visit the link.

AFCR’s BRACE Award Venture Competition is designed to support and accelerate oncology innovations on their path toward commercialization, aiming to improve outcomes for patients affected by cancer globally.”

Source: Asian Fund for Cancer Research/LinkedIn

AFCR Asian Fund for Cancer Research BRACE Award Venture Competition cancer Concarlo Therapeutics OncoDaily Oncology Orphagen Pharmaceuticals Scott Thacher Stacy Blain

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology